Randomized, double-blind, placebo-controlled, safety, tolerability, PK, PD and exploratory efficacy phase 1b/2a trial with AC01 in patients with HFrEF

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Advances in heart failure detection and therapy Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by